Antiepileptics, Parenteral

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Current Drug Use Criteria New Drug Evaluation
brivaracetam BRIVIACT VIAL N   Jul 28, 2016
fosphenytoin sodium FOSPHENYTOIN SODIUM VIAL    
fosphenytoin sodium CEREBYX VIAL    
lacosamide LACOSAMIDE VIAL    
lacosamide VIMPAT VIAL    
levetiracetam KEPPRA VIAL    
levetiracetam LEVETIRACETAM VIAL    
levetiracetam in NaCl (iso-os) LEVETIRACETAM-NACL PIGGYBACK    
phenytoin sodium PHENYTOIN SODIUM VIAL    
valproic acid (as sodium salt) VALPROATE SODIUM VIAL